Concepedia

Manoj Kumar

MK

Statistics

Publications

15

Citations

393

H-Index

14

Active since

2004

Affiliations

University of Wisconsin–Madison(Current)

University of Wisconsin Carbone Cancer Center

Huazhong University of Science and Technology

Tongji Hospital

Stanford University

Manoj Kumar is an author at University of Wisconsin–Madison specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2004–2022

15

Publications

15

Dendrimer-stabilized smart-nanoparticle (DSSN) platform for targeted delivery of hydrophobic antitumor therapeutics

Rakesh Kumar Tekade, Muktika Tekade, Manoj Kumar et al. · Pharmaceutical Research · 2014 · 73 citations

, , +6

Anti-angiogenic effects of somatostatin receptor subtype 2 on human pancreatic cancer xenografts

Manoj Kumar · Carcinogenesis · 2004 · 34 citations · Full text

, , +18

SU086, an inhibitor of HSP90, impairs glycolysis and represents a treatment strategy for advanced prostate cancer

Meghan A. Rice, Vineet Kumar, Dhanir Tailor et al. · Cell Reports Medicine · 2022 · 33 citations · Full text

Antiangiogenic effect of somatostatin receptor subtype 2 on pancreatic cancer cell line: Inhibition of vascular endothelial growth factor and matrix metalloproteinase-2 expression<i>in vitro</i>

Manoj Kumar, Zheng-Ren Liu, Laxmi Thapa et al. · World Journal of Gastroenterology · 2004 · 32 citations · Full text

MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer

En‐Chi Hsu, Michelle Shen, Merve Aslan et al. · Scientific Reports · 2021 · 32 citations · Full text

Rows per page

1–5 of 15